Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Share News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.80
Bid: 19.00
Ask: 20.40
Change: -4.80 (-19.59%)
Spread: 1.40 (7.368%)
Open: 22.60
High: 22.60
Low: 20.80
Prev. Close: 24.50
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: TP chair resigns amid pressure from Science Group

Fri, 29th Oct 2021 15:57

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and Friday and not separately reported by Alliance News:

----------

TP Group PLC - Wincanton, England-based consulting, software and engineering company - Philip Holland resigns as chair, effective immediately, having served for four years. Holland "made this decision in the best interests of the TP Group's employees and shareholders in order to enable the company to move forward with a new strategy", TP says. Science Group PLC, a 27% shareholder of TP, on Tuesday had requisitioned a general meeting to remove Holland, who had stepped up to chair in late September to replace Andrew McCree. Earlier this month, Martyn Ratcliffe and Peter Bertram joined the TP board to represent Science Group, which had failed in a hostile takeover offer for TP Group back in August.

----------

Futura Medical PLC - Guildford, Surrey-based pharmaceutical products for sexual health and pain - Hires Andrew Unitt as non-executive director, starting January 1. Unitt replaces Jonathan Freeman, who steps down as senior independent non-executive director on December 31. Unitt was with pharmacy chain Boots PLC for 11 years, including four as finance director of Boots Healthcare International, its over-the-counter medicines business. He currently is a non-executive director of AIM-listed diagnostics firm Oncimmune Holdings PLC.

----------

Baillie Gifford Shin Nippon PLC - invests for capital growth from small Japanese companies - Hires Claire Finn and Abigail Rotheroe as non-executive directors, with Finn starting on November 1 and Rotheroe on March 1 next year. Finn, a former executive at BlackRock Inc, is a director of London-listings Law Debenture Corp PLC and Octopus Apollo VCT PLC. Rotheroe is investment director for Snowball Impact Management, an asset manager focused on socially responsible investment. Rotheroe previously worked for Threadneedle Investments, managing Asia- and Japan-focused funds.

----------

Resolute Mining Ltd - Perth, Australia-based gold miner with projects in Mali, Senegal and Guinea - Hires Simon Jackson as non-executive director, starting Friday. Jackson replaces Yasmin Broughton, who resigned on Thursday, having served since 2017. Jackson has over 25 years experience managing mining companies, Resolute said, currently serving on several boards, including two as chair.

----------

Capital Metals PLC - mineral sands project in Sri Lanka - Hires James Mahony as chief financial officer, effective immediately, while Anthony Samaha steps down as finance director. Mahony is a partner in Westend Corporate LLP, which provides financial consulting and corporate management services. Additionally, Westend will take over as company secretary, replacing Sam Quinn.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 Sep 2020 16:06

IN BRIEF: Oncimmune Signs Autoantibody Profiling Programme Agreement

IN BRIEF: Oncimmune Signs Autoantibody Profiling Programme Agreement

Read more
2 Sep 2020 13:49

Oncimmune announces autoantibody profiling collaboration

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has signed an autoantibody profiling collaboration with an unnamed "leading global biopharmaceutical company", it announced on Wednesday, which it said had "extensive experience" in developing novel immune checkpoint inhibitors (CPIs).

Read more
27 Jul 2020 18:11

IN BRIEF: Oncimmune Notes Expanded Profiling Contract With Roche

IN BRIEF: Oncimmune Notes Expanded Profiling Contract With Roche

Read more
27 Jul 2020 09:22

Roche extends scope and value of contract with Oncimmune

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings announced on Monday that Roche has exercised its option to increase the scope and value of the cornerstone contract, initially announced on 28 May.

Read more
2 Jul 2020 06:54

IN BRIEF: Oncimmune's EarlyCDT Gets Marketing Authorisation In Brazil

IN BRIEF: Oncimmune's EarlyCDT Gets Marketing Authorisation In Brazil

Read more
5 Jun 2020 14:10

UK DIRECTOR DEALINGS SUMMARY: Avast Non-Exec Sells 500,000 Shares

UK DIRECTOR DEALINGS SUMMARY: Avast Non-Exec Sells 500,000 Shares

Read more
4 Jun 2020 13:19

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

UK TRADING UPDATE SUMMARY: Open Orphan Launches Covid Testing Service

Read more
4 Jun 2020 10:50

Oncimmune expects to report further strong top-line growth

(Sharecast News) - Immunodiagnostics group Oncimmune Holdings said on Thursday that it expects to report further strong top-line growth in its current trading year.

Read more
28 May 2020 15:32

Oncimmune Inks Further Roche Contract Focused On Immunotherapy Trials

Oncimmune Inks Further Roche Contract Focused On Immunotherapy Trials

Read more
12 May 2020 16:42

Oncimmune Signs Drug Development Deal With US Biopharmaceutical Firm

Oncimmune Signs Drug Development Deal With US Biopharmaceutical Firm

Read more
12 May 2020 15:32

Oncimmune signs collaboration deal with US biopharma company

(Sharecast News) - Immunodiagnostics company Oncimmune Holdings has signed an antigen-targeting collaboration, it announced on Tuesday, to support drug development with a "leading", unnamed United States biopharmaceutical company, which is developing novel therapies based on the human immune response.

Read more
6 May 2020 14:57

UK DIRECTOR DEALINGS SUMMARY: Burford Capital Chiefs Spend GBP425,000

UK DIRECTOR DEALINGS SUMMARY: Burford Capital Chiefs Spend GBP425,000

Read more
5 May 2020 11:50

UK EXECUTIVE CHANGE SUMMARY: Sigma Capital Taps Former Countryside CEO

UK EXECUTIVE CHANGE SUMMARY: Sigma Capital Taps Former Countryside CEO

Read more
18 Mar 2020 18:09

DIRECTOR DEALINGS SUMMARY: Wizz Air Chair Buys GBP700,000 In Shares

DIRECTOR DEALINGS SUMMARY: Wizz Air Chair Buys GBP700,000 In Shares

Read more
18 Mar 2020 07:30

UK Advisory Body Gives Oncimmune's Lung Cancer Test Positive Review

UK Advisory Body Gives Oncimmune's Lung Cancer Test Positive Review

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.